SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001072613-22-000603
Filing Date
2022-11-04
Accepted
2022-11-04 16:42:40
Documents
1
Group Members
DAVID M. MOTTFOREST BASKETTNEA 13 GP, LTDNEA PARTNERS 13, L.P.PATRICK J. KERINSPETER J. BARRISRAVI VISWANATHANSCOTT D. SANDELL

Document Format Files

Seq Description Document Type Size
1 NEW ENTERPRISE ASSOCIATES 13, LP (PHASEBIO PHARMACEUTICALS) - SCHEDULE 13D/A#1E nea13_18667.htm SC 13D/A 90579
  Complete submission text file 0001072613-22-000603.txt   92500
Mailing Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355
Business Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355 (610) 981-6500
PhaseBio Pharmaceuticals Inc (Subject) CIK: 0001169245 (see all company filings)

IRS No.: 030375697 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90691 | Film No.: 221362855
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1119 ST PAUL STREET BALTIMORE MD 21202
Business Address 1119 ST PAUL STREET BALTIMORE MD 21202 410-244-0115
NEW ENTERPRISE ASSOCIATES 13 LP (Filed by) CIK: 0001452907 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9
Type: SC 13D/A